Johnson & Johnson reported solid operational growth but highlighted significant currency headwinds that are expected to negatively impact 2015 reported sales and earnings more than anticipated. Despite management's confidence in their core businesses and robust product pipeline, the cautious guidance and emphasis on currency impacts may lead to short-term investor concern. Consequently, the stock is likely to face slight downward pressure in the next 1â€“2 weeks.

[-1]